Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Locatelli

Showing results (231-240 of 376) with videos related to

Pageof 38
Sort By:
Journal of the American Society of Nephrology : JASN|October 25, 2001
Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal diseaseFrancesco Locatelli, Daniele Marcelli, Ferruccio Conte, et al.
Kidney International|July 15, 2005
Mini-peritoneal equilibration test: A simple and fast method to assess free water and small solute transport across the peritoneal membraneVincenzo La Milia, Salvatore Di Filippo, Monica Crepaldi, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 9, 2020
[The CROFF pavilion at the Policlinico Hospital in Milan: the beginnings]Giovanni B Fogazzi, Diego Brancaccio, Claudio Ponticelli, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 2, 2010
Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) studyFrancesco Locatelli, Pedro Aljama, Bernard Canaud, et al.
The Cochrane Database of Systematic Reviews|September 14, 2012
High-flux versus low-flux membranes for end-stage kidney diseaseSuetonia C Palmer, Kannaiyan S Rabindranath, Jonathan C Craig, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 28, 2002
Nutritional status in dialysis patients: a European consensusFrancesco Locatelli, Denis Fouque, Olof Heimburger, et al.
Haematologica|November 25, 2014
Hypersensitivity reactions to intravenous iron: guidance for risk minimization and managementDavid Rampton, Joergen Folkersen, Steven Fishbane, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2003
Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trialClaudio Pozzi, Simeone Andrulli, Lucia Del Vecchio, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 24, 2020
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney diseaseRoberto Minutolo, Carlo Garofalo, Paolo Chiodini, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 9, 2009
Effect of MCI-196 on serum phosphate and cholesterol levels in haemodialysis patients with hyperphosphataemia: a double-blind, randomized, placebo-controlled studyFrancesco Locatelli, Nada Dimkovic, Giuseppe Pontoriero, et al.
Pageof 38

Showing results (231-240 of 376) with videos related to

Sort By:
Pageof 38
Journal of the American Society of Nephrology : JASN|October 25, 2001
Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal diseaseFrancesco Locatelli, Daniele Marcelli, Ferruccio Conte, et al.
Kidney International|July 15, 2005
Mini-peritoneal equilibration test: A simple and fast method to assess free water and small solute transport across the peritoneal membraneVincenzo La Milia, Salvatore Di Filippo, Monica Crepaldi, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 9, 2020
[The CROFF pavilion at the Policlinico Hospital in Milan: the beginnings]Giovanni B Fogazzi, Diego Brancaccio, Claudio Ponticelli, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 2, 2010
Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) studyFrancesco Locatelli, Pedro Aljama, Bernard Canaud, et al.
The Cochrane Database of Systematic Reviews|September 14, 2012
High-flux versus low-flux membranes for end-stage kidney diseaseSuetonia C Palmer, Kannaiyan S Rabindranath, Jonathan C Craig, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 28, 2002
Nutritional status in dialysis patients: a European consensusFrancesco Locatelli, Denis Fouque, Olof Heimburger, et al.
Haematologica|November 25, 2014
Hypersensitivity reactions to intravenous iron: guidance for risk minimization and managementDavid Rampton, Joergen Folkersen, Steven Fishbane, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2003
Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trialClaudio Pozzi, Simeone Andrulli, Lucia Del Vecchio, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 24, 2020
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney diseaseRoberto Minutolo, Carlo Garofalo, Paolo Chiodini, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 9, 2009
Effect of MCI-196 on serum phosphate and cholesterol levels in haemodialysis patients with hyperphosphataemia: a double-blind, randomized, placebo-controlled studyFrancesco Locatelli, Nada Dimkovic, Giuseppe Pontoriero, et al.
Pageof 38